The new treatments for hepatitis C virus: An advanced practice provider's perspective

Publisher： John Wiley & Sons Inc

E-ISSN： 2046-2484|4|6|153-155

ISSN： 2046-2484

Source： CLINICAL LIVER DISEASE (ELECTRONIC), Vol.4, Iss.6, 2014-12, pp. : 153-155

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

What is the ethical responsibility of a provider when prescribing the new direct‐acting antiviral agents to patients with hepatitis C infection?

By  

CLINICAL LIVER DISEASE (ELECTRONIC), Vol. 6, Iss. 5, 2015-11 ,pp. : 117-119

John Wiley & Sons Inc

Access to resources Recommend Favorite

New treatments for HCV: Perspective from Asia

By  

CLINICAL LIVER DISEASE (ELECTRONIC), Vol. 5, Iss. 1, 2015-01 ,pp. : 17-21

John Wiley & Sons Inc

Access to resources Recommend Favorite

New therapies for hepatitis C: Latin American perspectives

By  

CLINICAL LIVER DISEASE (ELECTRONIC), Vol. 5, Iss. 1, 2015-01 ,pp. : 8-10

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of patients with hepatitis C virus genotype 3: Where are we now?

By  

CLINICAL LIVER DISEASE (ELECTRONIC), Vol. 6, Iss. 4, 2015-10 ,pp. : 79-81

John Wiley & Sons Inc

Access to resources Recommend Favorite

The price of shortening anti–hepatitis C virus therapy: Is this truly cost saving?

By  

CLINICAL LIVER DISEASE (ELECTRONIC), Vol. 6, Iss. 5, 2015-11 ,pp. : 126-128

John Wiley & Sons Inc

Access to resources Recommend Favorite